- Why Research
- Our Impact
- Get Involved
- About BCRF
- Contact Us
- Cancer Divides. We Unite.
You are here
Lewis A. Chodosh, MD, PhD
J. Samuel Staub Professor
Chair, Department of Cancer Biology
Abramson Family Cancer Research Institute
University of Pennsylvania, Perelman School of Medicine
Seeking to understand the mechanisms by which breast cancers develop, become resistant to therapy, and become lethal.
Experiments are ongoing to study the process by which breast cancer cells survive anti-cancer therapy and recur years later.
These studies will enable future efforts to identify women at elevated risk for breast cancer and the development of strategies to prevent recurrence.
The principal cause of death from breast cancer is tumor recurrence, which can occur 20 years or more after treatment of the original breast cancer. Mounting evidence suggests that recurrent breast cancers are fundamentally different from the primary breast cancers from which they arose. Consequently, drugs that are effective against primary tumors may be ineffective against tumors that have recurred.
Identifying the specific pathways and genes responsible for breast cancer recurrence may provide critical new drug targets essential for the development of more effective therapies. Dr. Chodish and his team are using laboratory models for human breast cancer to elucidate the mechanisms that allow breast cancer cells to survive therapy and recur years after treatment of the originally diagnosed breast cancer.
These studies have the potential to identify mechanisms of therapeutic resistance in breast cancers and, in doing so, to identify promising new approaches to prevent cancer recurrence.
In a separate study, Dr. Chodish is examining weight loss and exercise, which are frequently recommended to breast cancer survivors. They will test whether these behavioral interventions can prevent breast cancer recurrence.
Dr. Lewis A. Chodosh is a physician-scientist who received a BS in Molecular Biophysics and Biochemistry from Yale University, and MD from Harvard Medical School, and a PhD. in Biochemistry from M.I.T. in the laboratory of Dr. Phillip Sharp. He performed his clinical training in Internal Medicine and Endocrinology at the Massachusetts General Hospital, after which he was a postdoctoral research fellow with Dr. Philip Leder at Harvard Medical School. Dr. Chodosh joined the faculty of the University of Pennsylvania in 1994, where he is currently a Professor in the Departments of Cancer Biology, Cell & Developmental Biology, and Medicine. Dr. Chodosh serves as Chairman of the Department of Cancer Biology, Associate Director for Basic Science of the Abramson Cancer Center, and Director of Cancer Genetics for the Abramson Family Cancer Research Institute at the University of Pennsylvania. Dr. Chodosh also serves as Editor-in-Chief of Breast Cancer Research and is on the scientific advisory board for the Harvard Nurses' Health Studies I and II. His research focuses on genetic, genomic and molecular approaches to understanding breast cancer susceptibility and pathogenesis.